tetano
Editor, Senior Moderator
Sci Rep
. 2024 Oct 4;14(1):23057.
doi: 10.1038/s41598-024-73114-3. Rational design based on multi-monomer simultaneous docking for epitope imprinting of SARS-CoV-2 spike protein
Soumya Rajpal[SUP] 1 2 [/SUP], Alex D Batista[SUP] 1 3 [/SUP], Rüdiger Groß[SUP] 4 [/SUP], Jan Münch[SUP] 4 [/SUP], Boris Mizaikoff[SUP] 5 6 [/SUP], Prashant Mishra[SUP] 7 [/SUP]
Affiliations
Among biomimetic strategies shaping engineering designs, molecularly imprinted polymer (MIP) technology stands out, involving chemically synthesised receptors emulating natural antigen-antibody interactions. These versatile 'designer polymers' with remarkable stability and low cost, are pivotal for in vitro diagnostics. Amid the recent global health crisis, we probed MIPs' potential to capture SARS-CoV-2 virions. Large biotemplates complicate MIP design, influencing generated binding site specificity. To precisely structure recognition sites within polymers, we innovated an epitope imprinting method supplemented by in silico polymerization component screening. A viral surface Spike protein informed epitope selection was targeted for MIP development. A novel multi-monomer docking approach (MMSD) was employed to simulate classical receptor-ligand interactions, mimicking binding reinforcement across multiple amino acids. Around 40 monomer combinations were docked to the epitope sequence and top performers experimentally validated via rapid fluorescence binding assays. Notably, high imprinting factor polymers correlated with MMSD predictions, promising rational MIP design applicable to diverse viral pathologies.
. 2024 Oct 4;14(1):23057.
doi: 10.1038/s41598-024-73114-3. Rational design based on multi-monomer simultaneous docking for epitope imprinting of SARS-CoV-2 spike protein
Soumya Rajpal[SUP] 1 2 [/SUP], Alex D Batista[SUP] 1 3 [/SUP], Rüdiger Groß[SUP] 4 [/SUP], Jan Münch[SUP] 4 [/SUP], Boris Mizaikoff[SUP] 5 6 [/SUP], Prashant Mishra[SUP] 7 [/SUP]
Affiliations
- PMID: 39367029
- PMCID: PMC11452659
- DOI: 10.1038/s41598-024-73114-3
Among biomimetic strategies shaping engineering designs, molecularly imprinted polymer (MIP) technology stands out, involving chemically synthesised receptors emulating natural antigen-antibody interactions. These versatile 'designer polymers' with remarkable stability and low cost, are pivotal for in vitro diagnostics. Amid the recent global health crisis, we probed MIPs' potential to capture SARS-CoV-2 virions. Large biotemplates complicate MIP design, influencing generated binding site specificity. To precisely structure recognition sites within polymers, we innovated an epitope imprinting method supplemented by in silico polymerization component screening. A viral surface Spike protein informed epitope selection was targeted for MIP development. A novel multi-monomer docking approach (MMSD) was employed to simulate classical receptor-ligand interactions, mimicking binding reinforcement across multiple amino acids. Around 40 monomer combinations were docked to the epitope sequence and top performers experimentally validated via rapid fluorescence binding assays. Notably, high imprinting factor polymers correlated with MMSD predictions, promising rational MIP design applicable to diverse viral pathologies.